License Agreements in the Health Care Equipment & Supplies Industry

649 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License and Marketing Agreement by and between the Company and Celularity Inc., dated August 6, 2020
License Agreements
SANUWAVE Health, Inc.
Health Care Equipment & Supplies
NY
2020
License Agreement by and between the Registrant and AbbVie Global Enterprises Ltd., dated as of July 11, 2024
License Agreements
Sionna Therapeutics, Inc.
Health Care Equipment & Supplies
2025
License Agreement by and between the Registrant and Sanofi Genzyme, dated as of December 20, 2019, as amended
License Agreements
Sionna Therapeutics, Inc.
Health Care Equipment & Supplies
2025
License Agreement, dated as of March 27, 2024, by and between Maze Therapeutics, Inc. and Shionogi & Co., Ltd
License Agreements
Maze Therapeutics, Inc.
Health Care Equipment & Supplies
2025
License Agreement, dated December 20, 2023 between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd, University of Rijeka Faculty of Medicine, and...
License Agreements
INVO Bioscience, Inc.
2024
License Agreement, dated December 19, 2023, between Inserm Transfert, Cytovia Therapeutics, Inc., and NAYA Therapeutics, Inc (fka NAYA Biosciences, Inc
License Agreements
INVO Bioscience, Inc.
2024
Addendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement, dated August 1, 2024, by and between the Company and Aroa Biosurgery Ltd
License Agreements
TELA Bio, Inc.
2024
Technology License Agreement dated August 30, 2024 between Registrant and BioIntellisense, Inc
License Agreements
iRhythm Technologies, Inc.
2024
Contract Transfer and License Agreement, by and between the Registrant and Biocon Limited, dated October 1, 2019
License Agreements
Bicara Therapeutics Inc.
2024
Third Amendment to License Agreement, dated June 10, 2024, by and between the Company and MIL 6T, LLC
License Agreements
Apogee Therapeutics, Inc.
2024
Second Amendment to License Agreement, dated February 26, 2024, by and between the Company and MIL 6T, LLC
License Agreements
Apogee Therapeutics, Inc.
2024
First Amendment to License Agreement, dated December 4, 2023, by and between the Company and MIL 6T, LLC
License Agreements
Apogee Therapeutics, Inc.
2024
License Agreement, dated November 22, 2023, by and between the Company and MIL 6T, LLC
License Agreements
Apogee Therapeutics, Inc.
2024
Third License Agreement, dated April 21, 2024, by and between Cornell University and the Company
License Agreements
Lexeo Therapeutics, Inc.
2024
Second Amendment to License Agreement, dated May 17, 2024, by and between the Registrant and Vanderbilt University
License Agreements
Neumora Therapeutics, Inc.
2024
Amendment to the License, Supply and Contract Manufacturing Agreement, entered into on April 22, 2024 and effective as of May 1, 2024, by and between the Company and Synerx...
License Agreements
DELCATH SYSTEMS, INC.
2024
EXCLUSIVE LICENSE AGREEMENT WITH EQUITY
License Agreements
ACTUATE THERAPEUTICS, INC.
2024
License Agreement, dated March 31, 2015, as amended, between Northwestern University and the Registrant
License Agreements
ACTUATE THERAPEUTICS, INC.
2024
Exclusive License Agreement with Equity, dated April 6, 2015, as amended, between The Board of Trustees of the University of Illinois and the Registrant
License Agreements
ACTUATE THERAPEUTICS, INC.
2024
License Agreement, by and between the Registrant and ARE-SD Region No. 61, LLC, dated December 21, 2023
License Agreements
Rapport Therapeutics, Inc.
2024
Option and License Agreement, by and between the Registrant and Janssen Pharmaceutica NV, dated August 9, 2022, as amended
License Agreements
Rapport Therapeutics, Inc.
2024
Amendment No. 1 to License and Supply Agreement, dated June 24, 2022, by and between CARGO Therapeutics, Inc. and Oxford Biomedica (UK) Limited
License Agreements
CARGO Therapeutics, Inc.
2024
Amendment No. 3, dated February 11, 2024, to the First License Agreement, dated May 28, 2020, by and between LEXEO Therapeutics, Inc. and Cornell University (as amended by...
License Agreements
Lexeo Therapeutics, Inc.
2024
License Agreement between Aspira Womens Health Inc. and Dana-Farber Cancer Institute, Inc. effective March 20, 2023
License Agreements
VERMILLION, INC.
2024
Addendum to the Second Amended and Restated License, Product Development and Supply Umbrella Agreement, dated August 13, 2020, by and between the Company and Aroa Biosurgery Ltd
License Agreements
TELA Bio, Inc.
2024
Development and License Agreement by and among Coya Therapeutics, Inc., Dr. Reddy's Laboratories SA, and Dr. Reddy's Laboratories Ltd., dated December 5, 2023
License Agreements
Coya Therapeutics, Inc.
2024
License Agreement, dated February 3, 2023, by and between the Registrant and Janssen Pharmaceutica NV
License Agreements
Contineum Therapeutics, Inc.
2024
Third Amendment to the License Agreement between Lirum Therapeutics, Inc. and IGF Oncology, LLC
License Agreements
Lirum Therapeutics, Inc.
2024
Second Amendment to the License Agreement between Lirum Therapeutics, Inc. and IGF Oncology, LLC
License Agreements
Lirum Therapeutics, Inc.
2024
First Amendment to the License Agreement between Lirum Therapeutics, Inc. and IGF Oncology
License Agreements
Lirum Therapeutics, Inc.
2024
License Agreement between Lirum Therapeutics, Inc. and IGF Oncology, LLC dated January 12
License Agreements
Lirum Therapeutics, Inc.
2024
Patent License Agreement (License Number L-159-2021-0), dated May 27, 2021, between Kyverna Therapeutics, Inc. and the National Institutes of Health
License Agreements
Kyverna Therapeutics, Inc.
2024
Patent License Agreement (License Number L-158-2021-0), dated May 20, 2021, between Kyverna Therapeutics, Inc. and the National Institutes of Health
License Agreements
Kyverna Therapeutics, Inc.
2024
Benuvia License Agreement
License Agreements
Chromocell Therapeutics Corp
2024
First Amendment to License Agreement by and between Organon International GmbH and Dar Bioscience, Inc., entered into as of July 4, 2023
License Agreements
Dare Bioscience, Inc.
2023
Patent License Agreement, dated February 24, 2023, by and between the Registrant and the National Cancer Institute
License Agreements
CARGO Therapeutics, Inc.
2023
Patent License Agreement, dated March 16, 2022, by and between the Registrant and the National Cancer Institute
License Agreements
CARGO Therapeutics, Inc.
2023
License and Supply Agreement, dated June 24, 2022, by and between the Registrant and Oxford Biomedica (UK) Limited
License Agreements
CARGO Therapeutics, Inc.
2023
Amendment No. 1 to Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University
License Agreements
CARGO Therapeutics, Inc.
2023
Exclusive License Agreement effective August 1, 2022, by and between the Registrant and the Board of Trustees of the Leland Stanford Junior University
License Agreements
CARGO Therapeutics, Inc.
2023
License and Supply Agreement, dated June 24, 2022, by and between the Registrant and Oxford Biomedica (UK) Limited
License Agreements
CARGO Therapeutics, Inc.
2023